World Vaccine Congress Asia 2012 - list of sponsors & exhibitors


	GE Healthcare provides life science research products and biopharmaceutical manufacturing technologies. Over 90% of the current biopharmaceuticals therapies on the market are manufactured utilizing chromatography media from GE Healthcare. In... more ›	Platinum sponsor

	Merck Millipore is the Life Science division of Merck KGaA and offers a broad range of products used by pharmaceutical and biotechnology companies to develop and manufacture biopharmaceutical drugs safely and efficiently. We provide fully integrated ... more ›	Gold Sponsor

	Medicago is committed to provide highly effective and affordable vaccines based on proprietary VLPs and manufacturing technologies. Medicago is developing VLP vaccines to protect against influenza, using a transient expression system producing... more ›	Silver Sponsor

	California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable... more ›	Bronze sponsor

	Viroclinics Biosciences B.V. is a contract research and clinical diagnostic service organization with a consultative approach to understand client needs and address customizing clinical research programs. We provide an array of services including... more ›	Bronze Sponsor

	Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three... more ›	Innovative showcase sponsor

	Immune Targeting Systems (ITS) is a London based biotech company developing vaccines for mutating viruses underpinned by its DepoVaccine and High Density Antigen identification technology platforms. ITS’s lead program is a synthetic universal... more ›	Innovative biotech showcase sponsor


	Lonza offers world class technology platforms in the areas of GMP cell culture and viral-based therapeutic manufacturing, custom biotherapeutic culture media, a large selection of primary and stem cells and a full line of custom bioassays. Our... more ›	Exhibitor

	Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. Marken integrates Depot and Logistics services... more ›	Exhibitor

	With more than 25 years of experience in developing Critical Logistics Solutions, OCASA relies on a worldwide network of affiliates and branches strategically located around the globe in (North America, Latin America, Europe, Africa, and South East... more ›	Exhibitor

Visit the World Vaccine Congress Asia 2012 exhibition »
Download the brochure »

Attend ›

the awards

Developing effective production strategies for multi-vaccine manufacturing in Asia

Evaluating specific challenges associated with manufacturing different vaccines
Developing robust approaches to fully utilise production facility
Exploring the different strategies available for ensuring quality control and regulatory compliance

Growing vaccine pipeline value through effective partnering and investment strategies in Asia

Asia contains a wide variety of vaccine markets, each with different advantages due to cultural, economic and geographic differences. Identifying the right partners to develop vaccines from initial R&D through trials to commercialization requires a strategic and well defined approach.
This workshop will assist participants in understanding how to approach the Asian market for external research and development and how to successfully build a pipeline through strategic partnerships.

Transitioning existing biologics processes into single use technology platform to enable global deployment

Factors to consider before implementation: performance equivalency, quality, logistics and business needs
Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
Examining before and after implementation for optimum efficiency

Optimising cost-effective Japanese Encephalitis (JE) vaccine development in Asia

Evaluating current development on inactivated and live molecular JE vaccine for the global population
Tapping on lessons learnt from producing the vaccine in Asia
Case study: Assessing the long term immunity of live attenuated Japanese encephalitis chimeric virus vaccine

Innovative vaccine design: Important chemistry, manufacturing and controls (CMC) issues in adjuvant development

Uncovering new concepts and knowledge about innovative vaccine design; innate immunity and beyond
Tapping on advanced technologies of immune-manipulation and delivery system in Japan
Overcoming regulatory hurdles and harnessing the potential for adjuvants in Japan; key factors for very safe and efficacious vaccines

Innovative International Vaccine Developments

Leading global and Asian biotechs, pharmas and research institutes will showcase their latest vaccine developments looking for potential partners globally and across Asia. Potential partnerships run from research and development to licensing and collaboration in vaccine commercialization.

sponsor World Vaccine Congress Asia 2012 ›

Asia'a largest vaccine event